Table 1 Demographics by clinical group.

From: Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms

 

CHR-P

PLE

CLN

HC

N

273

120

82

146

M Age (SD)

23.40 (4.30)

23.70 (4.35)

23.95 (3.59)

23.58 (4.06)

Sex

 Female

67.30%

66.95%

61.73%

53.79%

 Male

32.70%

33.05%

38.27%

46.21%

Race

 African American

17.05%

16.95%

13.58%

13.79%

 American Indian1

0.76%

0.69%

0.00%

1.69%

 Asian

17.80%

22.03%

22.22%

31.72%

 Caucasian

51.52%

50.00%

53.09%

44.83%

 Multiracial

10.61%

6.78%

9.88%

8.28%

 Native Hawaiian or Other Pacific Islander1

0.76%

0.69%

0.00%

0.00%

 Unknown or not reporteda

1.52%

0.00%

1.23%

2.54%

Hispanic

14.45%

11.02%

12.35%

7.59%

Mdn Household Income

$60,000.00

$60,000.00

$95,500.00

$100,000.00

Current Medication

 Antidepressant

23.00%

24.00%

17.00%

8.60%

 Antipsychotic

6.50%

0.91%

0.00%

0.00%

 Mood stabilizer

6.20%

1.80%

1.30%

0.00%

 Stimulant

6.20%

2.70%

1.30%

0.74%

 Anxiolytic

7.30%

5.50%

4.00%

1.50%

Current Substance Use Disorderb

30.33%

21.98%

17.91%

00.00%

  1. CHR-P clinical high risk for psychosis, PLE psychosis like experiences (not meeting CHR-P criteria), CLN current or recent mental health diagnoses, and HC healthy controls.
  2. adue to low prevalence, these groups were combined for analyses. Only a small significant difference between groups was present for sex (p = 0.04) and, as noted below, when demographic variables were considered as a whole there were no differences between groups.
  3. bBased on the presence of any current SCID Substance Use Disorder.
Back to article page